Pliant Therapeutics Inc (PLRX) Live Share Price, Invest From India

Pliant Therapeutics Inc Stock Performance

as on April 21, 2026 at 6:59 am IST

Day's Low
Day's High
$1.16
Day's Price Range
$1.35
$1.28
9.38%
Downside
5.47%
Upside
52 Week's Low
52 Week's High
$1.09
52-Week Price Range
$1.95
$1.28
14.84%
Downside
52.34%
Upside

Pliant Therapeutics Inc share price movements today

Previous Close: $1.33
Open: $1.35
Volume: 4.4M
Day's Low - High: $1.16 - $1.35
52 Week Low - High: $1.09 - $1.95

Pliant Therapeutics Inc Historical Returns

1 Month Return: + 3.1 %
3 Month Return: + 3.91 %
1 Year Return: -8.9 %
3 Year Return: -95.44 %
5 Year Return: -95.28 %

Pliant Therapeutics Inc Stock Fundamentals & Key Indicators

Check Pliant Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$82.3M

EPS (TTM)

-1.5345

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-148.4M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-61.55%

Pliant Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pliant Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Pliant Therapeutics Inc	BUY	$82.3M	-95.28%	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$41.3B	127.64%	133.47	8.45%
Vertex Pharmaceuticals Inc	BUY	$112.2B	100.4%	28.82	32.94%
BeiGene, Ltd.	NA	$37.2B	NA	131.65	5.37%
Regeneron Pharmaceuticals Inc	BUY	$79.4B	48.8%	18.08	31.41%

Stock Returns calculator for Pliant Therapeutics Inc Stock including INR - Dollar returns

The Pliant Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Pliant Therapeutics Inc investment value today

Current value as on today

₹95,830

Returns

-₹4,170

(-4.17%)

Returns from Pliant Therapeutics Inc Stock

-₹12,329 (-12.33%)

Dollar Impact

₹8,159 (+8.16%)

Analyst Recommendation on Pliant Therapeutics Inc Stock

Based on 20 analysts

BUY

95.00%

Buy

5.00%

Hold

0.00%

Sell

Based on 20 analysts, 95% of analysts recommend a 'BUY' rating for Pliant Therapeutics Inc. Average target price of $2.67

Pliant Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Pliant Therapeutics Inc.

What analysts predicted

52.06%UPSIDE

Target Price

$2.67

Current Price

$1.28

Analyzed by

20 Analysts

Target

$2.67

Pliant Therapeutics Inc target price $2.67, a slight upside of 52.06% compared to current price of $1.28. According to 20 analysts rating.

Pliant Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Pliant Therapeutics Inc Stock has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.

Time period: March 22, 2026 to April 21, 2026

Change:-55% versus previous 30 day period

Pliant Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-4	4	-	-	-	2	-	-	-	-
Gross Profit	-2	4	0	0	0	1	0	0	-	0
Operating Income	-47	-47	-52	-60	-62	-53	-58	-45	-28	-21
EBITDA	-40	-40	-45	-54	-56	-48	-54	-42	-23	-28
Interest Expense	0	0	0	0	0	0	0	0	2	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-41	-41	-46	-55	-57	-49	-56	-43	-26	-23
Income Tax Expense	0	3	0	-	-	-	-	-	-	-
Net Income	-41	-41	-46	-55	-57	-49	-56	-43	-26	-23
Net Profit Margin	857.17%	-849.36%	0.00%	0.00%	0.00%	-2190.84%	0.00%	0.00%	0.00%	0.00%

Pliant Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	57	41	7	9	1	-	-
Gross Profit	0	57	41	7	9	1	-2	-1
Operating Income	-30	-1	-41	-19	-127	-184	-228	-150
EBITDA	-30	0	-40	-18	-118	-158	-205	-148
Interest Expense	-	0	0	0	0	1	3	2
Depreciation	0	1	1	1	1	1	2	1
Income Before Tax	-30	0	-41	-19	-123	-161	-210	-149
Income Tax Expense	0	0	-1	-1	-1	1	-	-
Net Income	-30	0	-39	-17	-123	-161	-210	-149
Net Profit Margin	0.00%	-1.11%	-95.05%	-236.49%	-1273.32%	-10211.14%	0.00%	0.00%

Pliant Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-41	-46	-55	-57	-49	-56	-43	-26	-23
Operating Cash Flow	-25	-30	-45	-32	-47	-48	-40	-21	-17
Investing Cash Flow	31	59	10	30	39	69	35	27	1
Financing Cash Flow	0	21	0	0	0	0	-	0	-32
Change in Cash	5	51	-33	0	-8	20	-5	6	-48

Pliant Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-30	0	-41	-97	-123	-161	-210	-149
Operating Cash Flow	-28	-2	-37	-75	-94	-116	-155	-128
Investing Cash Flow	-2	-17	-210	73	-150	-127	140	134
Financing Cash Flow	87	45	213	2	226	274	23	-31
Change in Cash	56	24	-34	0	-17	31	7	-25

Global Institutional Holdings in Pliant Therapeutics Inc

Funds	Holdings
Deep Track Capital, LP	6.43%
Morgan Stanley - Brokerage Accounts	5.66%
Great Point Partners LLC	1.38%
Prosight Management, LP	2.51%
BlackRock Inc	2.29%

See all

Insights on Pliant Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, -56.16M → -23.57M (in $), with an average increase of 35.3% per quarter
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 41.3% return, outperforming this stock by 51.4%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.3% return, outperforming this stock by 120.9%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 4.83M → 2.27M (in $), with an average decrease of 53.1% per quarter
NEGATIVE IMPACT
Price Dip
In the last 3 years, PLRX stock has moved down by -95.6%

About Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Organisation	Pliant Therapeutics Inc
Headquarters	331 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Industry	Biotechnology
CEO	Dr. Bernard Coulie M.B.A., M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Pliant Therapeutics Inc

Name	Title
Dr. Bernard Coulie M.B.A., M.D., Ph.D.	President, CEO & Director
Mr. Hal Chapman M.D.	Scientific Founder & Member of Scientific Advisory Board
Ms. Minnie Kuo	Chief Operating Officer
Ms. Delphine Imbert Ph.D.	Chief Technical Officer
Ms. Lily Cheung	Chief Human Resources Officer
Dr. Keith Lamont Cummings M.B.A., M.D.	Chief Financial Officer
Dr. Rik Derynck Ph.D.	Scientific Founder & Member of Scientific Advisory Board
Mr. Dean Sheppard M.D.	Scientific Founder & Member of Scientific Advisory Board
Mr. Christopher S. Keenan	Vice President of Investor Relations & Corporate Communications
Monica Sandberg Ph.D.	Vice President, Regulatory & Compliance

FAQs

What is Pliant Therapeutics Inc share price today?

Pliant Therapeutics Inc share price today is $1.28 as on April 21, 2026 at 1:29 am IST at the close of the market. Pliant Therapeutics Inc share today touched a day high of $1.35 and a low of $1.16.

What is the 52 week high and 52 week low for Pliant Therapeutics Inc share?

Pliant Therapeutics Inc share touched a 52 week high of $1.95 on October 27, 2025 and a 52 week low of $1.09 on February 5, 2026. Pliant Therapeutics Inc stock price today i.e. April 21, 2026 at 1:29 am IST is closed at $1.28,which is 34.36% down from its 52 week high and 17.43% up from its 52 week low.

What is Pliant Therapeutics Inc's market capitalisation today?

Pliant Therapeutics Inc market capitalisation is $0.00T as on April 21, 2026 at 1:29 am IST.

How to invest in Pliant Therapeutics Inc Stock (PLRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Pliant Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pliant Therapeutics Inc Shares that will get you 1.1719 shares as per Pliant Therapeutics Inc share price of $1.28 per share as on April 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Pliant Therapeutics Inc Stock (PLRX) from India?

Indian investors can start investing in Pliant Therapeutics Inc (PLRX) shares with as little as ₹93.107 or $1 (as of April 21, 2026 at 9:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹931.07 in Pliant Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on April 21, 2026 at 9:40 am IST). Based on Pliant Therapeutics Inc share’s latest price of $1.28 as on April 21, 2026 at 1:29 am IST, you will get 7.8125 shares of Pliant Therapeutics Inc. Learn more about fractional shares .

What are the returns that Pliant Therapeutics Inc has given to Indian investors in the last 5 years?

Pliant Therapeutics Inc stock has given -95.28% share price returns and 22.82% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?